 | • レポートコード：QY2207C3863 • 出版社/出版日：QYResearch / 2022年7月11日 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界のシクロスポリン点眼薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にシクロスポリン点眼薬の世界市場のxxx％を占める「0.0005」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のシクロスポリン点眼薬の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのシクロスポリン点眼薬市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのシクロスポリン点眼薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 シクロスポリン点眼薬のグローバル主要メーカーには、Xingqi Eye Drops、Nevakar、Allergan、Xiidra、Wavelight、Sun Pharma、North China Pharmaceutical、Zrun、Hengrui Medicine、Novaliq、Novartisなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 シクロスポリン点眼薬市場は、種類と用途によって区分されます。世界のシクロスポリン点眼薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 0.0005、0.0009、0.001 【用途別セグメント】 病院、クリニック、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - シクロスポリン点眼薬製品概要 - 種類別市場（0.0005、0.0009、0.001） - 用途別市場（病院、クリニック、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のシクロスポリン点眼薬販売量予測2017-2028 - 世界のシクロスポリン点眼薬売上予測2017-2028 - シクロスポリン点眼薬の地域別販売量 - シクロスポリン点眼薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別シクロスポリン点眼薬販売量 - 主要メーカー別シクロスポリン点眼薬売上 - 主要メーカー別シクロスポリン点眼薬価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（0.0005、0.0009、0.001） - シクロスポリン点眼薬の種類別販売量 - シクロスポリン点眼薬の種類別売上 - シクロスポリン点眼薬の種類別価格 ・用途別市場規模（病院、クリニック、その他） - シクロスポリン点眼薬の用途別販売量 - シクロスポリン点眼薬の用途別売上 - シクロスポリン点眼薬の用途別価格 ・北米市場 - 北米のシクロスポリン点眼薬市場規模（種類別、用途別） - 主要国別のシクロスポリン点眼薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのシクロスポリン点眼薬市場規模（種類別、用途別） - 主要国別のシクロスポリン点眼薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のシクロスポリン点眼薬市場規模（種類別、用途別） - 主要国別のシクロスポリン点眼薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のシクロスポリン点眼薬市場規模（種類別、用途別） - 主要国別のシクロスポリン点眼薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのシクロスポリン点眼薬市場規模（種類別、用途別） - 主要国別のシクロスポリン点眼薬市場規模（トルコ、サウジアラビア） ・企業情報 Xingqi Eye Drops、Nevakar、Allergan、Xiidra、Wavelight、Sun Pharma、North China Pharmaceutical、Zrun、Hengrui Medicine、Novaliq、Novartis ・産業チェーン及び販売チャネル分析 - シクロスポリン点眼薬の産業チェーン分析 - シクロスポリン点眼薬の原材料 - シクロスポリン点眼薬の生産プロセス - シクロスポリン点眼薬の販売及びマーケティング - シクロスポリン点眼薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - シクロスポリン点眼薬の産業動向 - シクロスポリン点眼薬のマーケットドライバー - シクロスポリン点眼薬の課題 - シクロスポリン点眼薬の阻害要因 ・主な調査結果 |
As an immunosuppressant, cyclosporine eye drops can not only achieve precise anti-inflammatory effects on dry eye, but also promote tear and mucin secretion, so as to meet the long-term medication needs of patients due to repeated attacks.
Market Analysis and Insights: Global Cyclosporine Eye Drops Market
Due to the COVID-19 pandemic, the global Cyclosporine Eye Drops market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, 0.0005 accounting for % of the Cyclosporine Eye Drops global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Cyclosporine Eye Drops market size is valued at US$ million in 2021, while the US and Europe Cyclosporine Eye Drops are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Cyclosporine Eye Drops landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Cyclosporine Eye Drops include Xingqi Eye Drops, Nevakar, Allergan, Xiidra, Wavelight, Sun Pharma, North China Pharmaceutical, Zrun and Hengrui Medicine, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Cyclosporine Eye Drops Scope and Segment
Cyclosporine Eye Drops market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Cyclosporine Eye Drops market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
0.0005
0.0009
0.001
Segment by Application
Hospital
Clinic
Others
By Company
Xingqi Eye Drops
Nevakar
Allergan
Xiidra
Wavelight
Sun Pharma
North China Pharmaceutical
Zrun
Hengrui Medicine
Novaliq
Novartis
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Cyclosporine Eye Drops Product Introduction
1.2 Market by Type
1.2.1 Global Cyclosporine Eye Drops Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 0.0005
1.2.3 0.0009
1.2.4 0.001
1.3 Market by Application
1.3.1 Global Cyclosporine Eye Drops Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Cyclosporine Eye Drops Sales Estimates and Forecasts 2017-2028
2.2 Global Cyclosporine Eye Drops Revenue Estimates and Forecasts 2017-2028
2.3 Global Cyclosporine Eye Drops Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Cyclosporine Eye Drops Sales by Region
2.4.1 Global Cyclosporine Eye Drops Sales by Region (2017-2022)
2.4.2 Global Sales Cyclosporine Eye Drops by Region (2023-2028)
2.5 Global Cyclosporine Eye Drops Revenue by Region
2.5.1 Global Cyclosporine Eye Drops Revenue by Region (2017-2022)
2.5.2 Global Cyclosporine Eye Drops Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Cyclosporine Eye Drops Sales by Manufacturers
3.1.1 Global Top Cyclosporine Eye Drops Manufacturers by Sales (2017-2022)
3.1.2 Global Cyclosporine Eye Drops Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Cyclosporine Eye Drops in 2021
3.2 Global Cyclosporine Eye Drops Revenue by Manufacturers
3.2.1 Global Cyclosporine Eye Drops Revenue by Manufacturers (2017-2022)
3.2.2 Global Cyclosporine Eye Drops Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Cyclosporine Eye Drops Revenue in 2021
3.3 Global Cyclosporine Eye Drops Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Cyclosporine Eye Drops Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Cyclosporine Eye Drops Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Cyclosporine Eye Drops Sales by Type
4.1.1 Global Cyclosporine Eye Drops Historical Sales by Type (2017-2022)
4.1.2 Global Cyclosporine Eye Drops Forecasted Sales by Type (2023-2028)
4.1.3 Global Cyclosporine Eye Drops Sales Market Share by Type (2017-2028)
4.2 Global Cyclosporine Eye Drops Revenue by Type
4.2.1 Global Cyclosporine Eye Drops Historical Revenue by Type (2017-2022)
4.2.2 Global Cyclosporine Eye Drops Forecasted Revenue by Type (2023-2028)
4.2.3 Global Cyclosporine Eye Drops Revenue Market Share by Type (2017-2028)
4.3 Global Cyclosporine Eye Drops Price by Type
4.3.1 Global Cyclosporine Eye Drops Price by Type (2017-2022)
4.3.2 Global Cyclosporine Eye Drops Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Cyclosporine Eye Drops Sales by Application
5.1.1 Global Cyclosporine Eye Drops Historical Sales by Application (2017-2022)
5.1.2 Global Cyclosporine Eye Drops Forecasted Sales by Application (2023-2028)
5.1.3 Global Cyclosporine Eye Drops Sales Market Share by Application (2017-2028)
5.2 Global Cyclosporine Eye Drops Revenue by Application
5.2.1 Global Cyclosporine Eye Drops Historical Revenue by Application (2017-2022)
5.2.2 Global Cyclosporine Eye Drops Forecasted Revenue by Application (2023-2028)
5.2.3 Global Cyclosporine Eye Drops Revenue Market Share by Application (2017-2028)
5.3 Global Cyclosporine Eye Drops Price by Application
5.3.1 Global Cyclosporine Eye Drops Price by Application (2017-2022)
5.3.2 Global Cyclosporine Eye Drops Price Forecast by Application (2023-2028)
6 North America
6.1 North America Cyclosporine Eye Drops Market Size by Type
6.1.1 North America Cyclosporine Eye Drops Sales by Type (2017-2028)
6.1.2 North America Cyclosporine Eye Drops Revenue by Type (2017-2028)
6.2 North America Cyclosporine Eye Drops Market Size by Application
6.2.1 North America Cyclosporine Eye Drops Sales by Application (2017-2028)
6.2.2 North America Cyclosporine Eye Drops Revenue by Application (2017-2028)
6.3 North America Cyclosporine Eye Drops Market Size by Country
6.3.1 North America Cyclosporine Eye Drops Sales by Country (2017-2028)
6.3.2 North America Cyclosporine Eye Drops Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Cyclosporine Eye Drops Market Size by Type
7.1.1 Europe Cyclosporine Eye Drops Sales by Type (2017-2028)
7.1.2 Europe Cyclosporine Eye Drops Revenue by Type (2017-2028)
7.2 Europe Cyclosporine Eye Drops Market Size by Application
7.2.1 Europe Cyclosporine Eye Drops Sales by Application (2017-2028)
7.2.2 Europe Cyclosporine Eye Drops Revenue by Application (2017-2028)
7.3 Europe Cyclosporine Eye Drops Market Size by Country
7.3.1 Europe Cyclosporine Eye Drops Sales by Country (2017-2028)
7.3.2 Europe Cyclosporine Eye Drops Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Cyclosporine Eye Drops Market Size by Type
8.1.1 Asia Pacific Cyclosporine Eye Drops Sales by Type (2017-2028)
8.1.2 Asia Pacific Cyclosporine Eye Drops Revenue by Type (2017-2028)
8.2 Asia Pacific Cyclosporine Eye Drops Market Size by Application
8.2.1 Asia Pacific Cyclosporine Eye Drops Sales by Application (2017-2028)
8.2.2 Asia Pacific Cyclosporine Eye Drops Revenue by Application (2017-2028)
8.3 Asia Pacific Cyclosporine Eye Drops Market Size by Region
8.3.1 Asia Pacific Cyclosporine Eye Drops Sales by Region (2017-2028)
8.3.2 Asia Pacific Cyclosporine Eye Drops Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Cyclosporine Eye Drops Market Size by Type
9.1.1 Latin America Cyclosporine Eye Drops Sales by Type (2017-2028)
9.1.2 Latin America Cyclosporine Eye Drops Revenue by Type (2017-2028)
9.2 Latin America Cyclosporine Eye Drops Market Size by Application
9.2.1 Latin America Cyclosporine Eye Drops Sales by Application (2017-2028)
9.2.2 Latin America Cyclosporine Eye Drops Revenue by Application (2017-2028)
9.3 Latin America Cyclosporine Eye Drops Market Size by Country
9.3.1 Latin America Cyclosporine Eye Drops Sales by Country (2017-2028)
9.3.2 Latin America Cyclosporine Eye Drops Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Cyclosporine Eye Drops Market Size by Type
10.1.1 Middle East and Africa Cyclosporine Eye Drops Sales by Type (2017-2028)
10.1.2 Middle East and Africa Cyclosporine Eye Drops Revenue by Type (2017-2028)
10.2 Middle East and Africa Cyclosporine Eye Drops Market Size by Application
10.2.1 Middle East and Africa Cyclosporine Eye Drops Sales by Application (2017-2028)
10.2.2 Middle East and Africa Cyclosporine Eye Drops Revenue by Application (2017-2028)
10.3 Middle East and Africa Cyclosporine Eye Drops Market Size by Country
10.3.1 Middle East and Africa Cyclosporine Eye Drops Sales by Country (2017-2028)
10.3.2 Middle East and Africa Cyclosporine Eye Drops Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Xingqi Eye Drops
11.1.1 Xingqi Eye Drops Corporation Information
11.1.2 Xingqi Eye Drops Overview
11.1.3 Xingqi Eye Drops Cyclosporine Eye Drops Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Xingqi Eye Drops Cyclosporine Eye Drops Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Xingqi Eye Drops Recent Developments
11.2 Nevakar
11.2.1 Nevakar Corporation Information
11.2.2 Nevakar Overview
11.2.3 Nevakar Cyclosporine Eye Drops Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Nevakar Cyclosporine Eye Drops Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Nevakar Recent Developments
11.3 Allergan
11.3.1 Allergan Corporation Information
11.3.2 Allergan Overview
11.3.3 Allergan Cyclosporine Eye Drops Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Allergan Cyclosporine Eye Drops Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Allergan Recent Developments
11.4 Xiidra
11.4.1 Xiidra Corporation Information
11.4.2 Xiidra Overview
11.4.3 Xiidra Cyclosporine Eye Drops Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Xiidra Cyclosporine Eye Drops Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Xiidra Recent Developments
11.5 Wavelight
11.5.1 Wavelight Corporation Information
11.5.2 Wavelight Overview
11.5.3 Wavelight Cyclosporine Eye Drops Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Wavelight Cyclosporine Eye Drops Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Wavelight Recent Developments
11.6 Sun Pharma
11.6.1 Sun Pharma Corporation Information
11.6.2 Sun Pharma Overview
11.6.3 Sun Pharma Cyclosporine Eye Drops Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Sun Pharma Cyclosporine Eye Drops Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sun Pharma Recent Developments
11.7 North China Pharmaceutical
11.7.1 North China Pharmaceutical Corporation Information
11.7.2 North China Pharmaceutical Overview
11.7.3 North China Pharmaceutical Cyclosporine Eye Drops Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 North China Pharmaceutical Cyclosporine Eye Drops Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 North China Pharmaceutical Recent Developments
11.8 Zrun
11.8.1 Zrun Corporation Information
11.8.2 Zrun Overview
11.8.3 Zrun Cyclosporine Eye Drops Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Zrun Cyclosporine Eye Drops Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Zrun Recent Developments
11.9 Hengrui Medicine
11.9.1 Hengrui Medicine Corporation Information
11.9.2 Hengrui Medicine Overview
11.9.3 Hengrui Medicine Cyclosporine Eye Drops Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Hengrui Medicine Cyclosporine Eye Drops Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Hengrui Medicine Recent Developments
11.10 Novaliq
11.10.1 Novaliq Corporation Information
11.10.2 Novaliq Overview
11.10.3 Novaliq Cyclosporine Eye Drops Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Novaliq Cyclosporine Eye Drops Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Novaliq Recent Developments
11.11 Novartis
11.11.1 Novartis Corporation Information
11.11.2 Novartis Overview
11.11.3 Novartis Cyclosporine Eye Drops Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Novartis Cyclosporine Eye Drops Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Novartis Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Cyclosporine Eye Drops Industry Chain Analysis
12.2 Cyclosporine Eye Drops Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Cyclosporine Eye Drops Production Mode & Process
12.4 Cyclosporine Eye Drops Sales and Marketing
12.4.1 Cyclosporine Eye Drops Sales Channels
12.4.2 Cyclosporine Eye Drops Distributors
12.5 Cyclosporine Eye Drops Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Cyclosporine Eye Drops Industry Trends
13.2 Cyclosporine Eye Drops Market Drivers
13.3 Cyclosporine Eye Drops Market Challenges
13.4 Cyclosporine Eye Drops Market Restraints
14 Key Findings in The Global Cyclosporine Eye Drops Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer